OBJECTIVE: The echocardiogram (ECC) is not available to all Spanish General Practitioners (GP) despite its proven benefits in prevalent diseases, such as hypertension and heart failure. STUDY OBJECTIVE: To analyse the clinical adequacy of the application, performance, and diagnostic and therapeutic decisions of ECC indicated by the GP. DESIGN: Descriptive, cross-sectional, retrospective, multicentre study. SETTING: Primary care. Four health centres (HC). PARTICIPANTS: A total of 684 patients over 18 years who had an ECC performed in 2006-2007. MAIN MEASUREMENTS: A review of medical records and the ECC report. The socio-demographic variables, clinical and diagnostic performance were also evaluated. RESULTS: The majority of patients (62.3%) were ≥ 65 years, of which 61.8% were female The most frequent reasons for performing ECC were (but not limited to): heart failure: 30%, suspected valvular disease: 26%; suspected cardiomyopathy: 24.3%. Adequacy of the ECC: 84% (95% CI: 81.09-86.7%) with differences by age (p=.02), HC teaching (p<.001), comorbidity (p<.001) and abnormal ECC (p<.001). A disease was found in 80% of ECC, with differences according to age (p<.001), comorbidity (p=0.02), cardiovascular risk factors (p<.001) and degree of appropriateness of ECC (p=.001). The most common findings (but not limited to) included: valvular heart disease (61.6%) left ventricular hypertrophy (43%) diastolic dysfunction (28.2%). The results of the ECC helped make decisions in 35.2%, with 17.1% referred to cardiology, 10.5% treatment change and 9.6% other tests. CONCLUSIONS: We found that the application of ECC was highly appropriate. The results of ECC drive clinical decisions in a high percentage of cases. The ECC should be accessible to all GP.
OBJECTIVE: The echocardiogram (ECC) is not available to all Spanish General Practitioners (GP) despite its proven benefits in prevalent diseases, such as hypertension and heart failure. STUDY OBJECTIVE: To analyse the clinical adequacy of the application, performance, and diagnostic and therapeutic decisions of ECC indicated by the GP. DESIGN: Descriptive, cross-sectional, retrospective, multicentre study. SETTING: Primary care. Four health centres (HC). PARTICIPANTS: A total of 684 patients over 18 years who had an ECC performed in 2006-2007. MAIN MEASUREMENTS: A review of medical records and the ECC report. The socio-demographic variables, clinical and diagnostic performance were also evaluated. RESULTS: The majority of patients (62.3%) were ≥ 65 years, of which 61.8% were female The most frequent reasons for performing ECC were (but not limited to): heart failure: 30%, suspected valvular disease: 26%; suspected cardiomyopathy: 24.3%. Adequacy of the ECC: 84% (95% CI: 81.09-86.7%) with differences by age (p=.02), HC teaching (p<.001), comorbidity (p<.001) and abnormal ECC (p<.001). A disease was found in 80% of ECC, with differences according to age (p<.001), comorbidity (p=0.02), cardiovascular risk factors (p<.001) and degree of appropriateness of ECC (p=.001). The most common findings (but not limited to) included: valvular heart disease (61.6%) left ventricular hypertrophy (43%) diastolic dysfunction (28.2%). The results of the ECC helped make decisions in 35.2%, with 17.1% referred to cardiology, 10.5% treatment change and 9.6% other tests. CONCLUSIONS: We found that the application of ECC was highly appropriate. The results of ECC drive clinical decisions in a high percentage of cases. The ECC should be accessible to all GP.
Authors: F Lombera Romero; V Barrios Alonso; F Soria Arcos; L Placer Peralta; J M Cruz Fernández; L Tomás Abadal; L Rodríguez Padial; J R González Juanatey Journal: Rev Esp Cardiol Date: 2000-01 Impact factor: 4.753
Authors: Carmen Suárez; José Villar; Nieves Martel; Blas Gil Extremera; Najaty Suliman; Carlos Campo; Victoriano Castellanos; Antonio Liébana; Enrique Rodilla; Javier Nieto; Olga Velasco; Luis M Ruilope Journal: Int J Cardiol Date: 2006-01-04 Impact factor: 4.164
Authors: Leanne M S G van Heur; Leo H B Baur; Marleen Tent; Cara L B Lodewijks-van der Bolt; Marjolijn Streppel; Ron A G Winkens; Henri E J H Stoffers Journal: BMC Health Serv Res Date: 2010-02-10 Impact factor: 2.655
Authors: María A Martinez; Teresa Sancho; Eduardo Armada; José M Rubio; José L Antón; Alberto Torre; Javier Palau; Paloma Seguido; Jaime Gallo; Isabel Saenz; Enrique Polo; Rosa Torres; José Oliver; Juan G Puig Journal: Am J Hypertens Date: 2003-07 Impact factor: 2.689
Authors: J Mant; J Doust; A Roalfe; P Barton; M R Cowie; P Glasziou; D Mant; R J McManus; R Holder; J Deeks; K Fletcher; M Qume; S Sohanpal; S Sanders; F D R Hobbs Journal: Health Technol Assess Date: 2009-07 Impact factor: 4.014